Funding for this research was provided by:
National Institutes of Health (HL007188, HL087000, HL078522, HL079233, HD052102, HL094100, HL087708, CA127642, CA068484, HL053392, HD052104, HL072705, AI50274, HL004537, HD028820, HD80002, HL095127)
Roche Diagnostics (n/a)
Children's Cardiomyopathy Foundation (n/a)
Sofia’s Hope, Inc (n/a)
the Kyle John Rymiszewski Foundation (n/a)
the Children’s Hospital of Michigan Foundation (n/a)
the Scott Howard Fund (n/a)
the Michael Garil Fund (n/a)
Received: 2 May 2019
Accepted: 16 October 2019
First Online: 2 December 2019
Ethics approval and consent to participate
: Not applicable (review article).
: Not applicable.
: Rudolf Steiner: Oncology Consultant to Clinigen Group PLC, UK.Steven Lipshultz: Cardiology Consultant to Clinigen Group PLC, UK.Rest of the Authors: None.